Evidence that soyasaponin Bb retards disease progression in a murine model of polycystic kidney disease
- 1 April 2003
- journal article
- Published by Elsevier in Kidney International
- Vol. 63 (4), 1230-1239
- https://doi.org/10.1046/j.1523-1755.2003.00869.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitorKidney International, 2000
- Mechanism of Maxi-K Channel Activation by Dehydrosoyasaponin-IThe Journal of general physiology, 1998
- Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease.JCI Insight, 1998
- The effects of purified alcohol extracts from soy products on feed intake and growth of chinook salmon (Oncorhynchus tshawytscha) and rainbow trout (Oncorhynchus mykiss)Aquaculture, 1998
- High-conductance calcium-activated potassium channels; Structure, pharmacology, and functionJournal of Bioenergetics and Biomembranes, 1996
- Tyrosine kinase activity of the EGF receptor in murine metanephric organ cultureKidney International, 1995
- Progression of Chronic Renal Failure in a Rat Strain with Autosomal Dominant Polycystic Kidney DiseaseNephron, 1994
- Autosomal-dominant polycystic kidney disease in the ratKidney International, 1993
- Saponin composition of 13 varieties of legume seed using fast atom bombardment mass spectrometryJournal of the Science of Food and Agriculture, 1988
- Saponin and sapogenol. XXXVIII. Structure of soyasaponin A2, a bisdesmoside of soyasapogenol A, from soybean, the seeds of Glycine max Merrill.CHEMICAL & PHARMACEUTICAL BULLETIN, 1985